Healthcare -
Biotechnology - NASDAQ - FR
$ 1.69
1.2 %
$ 142 M
Market Cap
-3.93
P/E
IPHA - GROSS PROFIT
Gross Profit IPHA - Innate Pharma S.A.
-4.12 M
LAST VALUE
65.63%
2 YEAR CAGR
-6.94%
5 YEAR CAGR
-6.30%
10 YEAR CAGR